These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1823222)

  • 1. Functional and ultrastructural evaluation of myocardial protection provided by intermittent coronary sinus perfusion in the isolated dog heart.
    De-Andrade RR; Tucci PJ; Silva MA; Oliveira RA; Gregorio EA; Curi PR; Hossne WS
    Braz J Med Biol Res; 1991; 24(1):81-91. PubMed ID: 1823222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of myocardial protective effects between GIK solution and St. Thomas solution by use of canine isolated heart-lung preparations].
    Ina H; Yasuda I
    Nihon Kyobu Geka Gakkai Zasshi; 1989 Nov; 37(11):2318-27. PubMed ID: 2693545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does simultaneous antegrade/retrograde cardioplegia improve myocardial perfusion in the areas at risk? A magnetic resonance perfusion imaging study in isolated pig hearts.
    Tian G; Shen J; Sun J; Xiang B; Oriaku GI; Zhezong L; Scarth G; Somorjai R; Saunders JK; Salerno TA; Deslauriers R
    J Thorac Cardiovasc Surg; 1998 Apr; 115(4):913-24. PubMed ID: 9576229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Functional and metabolic effects of nicardipine on ischemic rat hearts with multidose potassium cardioplegia].
    Tachibana H
    Nihon Kyobu Geka Gakkai Zasshi; 1990 Apr; 38(4):630-40. PubMed ID: 2373897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of antegrade cardioplegic infusion with simultaneously controlled coronary sinus occlusion on preservation of regionally ischemic myocardium after acute coronary artery occlusion and reperfusion.
    Sun SC; Raza ST; Tam SK; Laurence R; Cohn LH
    J Thorac Cardiovasc Surg; 1988 Oct; 96(4):626-33. PubMed ID: 3172809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of crystalloid cardioplegic protection against global normothermic ischemia by superoxide dismutase plus catalase but not diltiazem in the isolated, working rat heart.
    Greenfield DT; Greenfield LJ; Hess ML
    J Thorac Cardiovasc Surg; 1988 May; 95(5):799-813. PubMed ID: 3361928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid cooling contracture of the myocardium. The adverse effect of prearrest cardiac hypothermia.
    Rebeyka IM; Hanan SA; Borges MR; Lee KF; Yeh T; Tuchy GE; Abd-Elfattah AS; Williams WG; Wechsler AS
    J Thorac Cardiovasc Surg; 1990 Aug; 100(2):240-9. PubMed ID: 2385121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experimental study on myocardial protection by means of retrograde coronary sinus cooling perfusion (RCSP) during aorto-coronary bypass surgery].
    Watanabe F
    Hokkaido Igaku Zasshi; 1987 Jul; 62(4):544-57. PubMed ID: 3315925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of oxygenated University of Wisconsin solution containing endothelin-A receptor antagonist in twenty-four-hour heart preservation.
    Okada K; Yamashita C; Okada M; Okada M
    J Heart Lung Transplant; 1996 May; 15(5):475-84. PubMed ID: 8771503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of controlled reperfusion after ischemia. XXIII. Deleterious effects of simulated thrombolysis preceding simulated coronary artery bypass grafting with controlled blood cardioplegic reperfusion.
    Quillen J; Kofsky ER; Buckberg GD; Partington MT; Julia PL; Acar C
    J Thorac Cardiovasc Surg; 1991 Mar; 101(3):455-64. PubMed ID: 1999939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac efficiency during coronary occlusion and during reperfusion after emergency revascularization under cardioprotection.
    Kantartzis M; Sunderdiek U; Bircks W; Arnold G; Schipke JD
    Thorac Cardiovasc Surg; 1996 Feb; 44(1):20-6. PubMed ID: 8721396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human albumin enriched St. Thomas Hospital cardioplegic solution increases reperfusion injury in isolated perfused rat hearts.
    Süzer O; Köseoğlu S; Ozüner Z
    Pharmacol Res; 1998 Feb; 37(2):97-101. PubMed ID: 9572063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of endogenous nitric oxide on cardiac systolic and diastolic function during ischemia and reperfusion in the rat isolated perfused heart.
    Pabla R; Curtis MJ
    J Mol Cell Cardiol; 1996 Oct; 28(10):2111-21. PubMed ID: 8930806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial protection by intermittent perfusion with cardioplegic solution versus intermittent coronary perfusion with cold blood.
    Laks H; Barner HB; Standeven JW; Hahn JW; Jellinek M; Menz LJ
    J Thorac Cardiovasc Surg; 1978 Aug; 76(2):158-72. PubMed ID: 682649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of myocardial reperfusion injury by poly(ADP-ribose) synthetase inhibitor, 3-aminobenzamide, in cardioplegic solution: in vitro study of isolated rat heart model.
    Yamazaki K; Miwa S; Ueda K; Tanaka S; Toyokuni S; Unimonh O; Nishimura K; Komeda M
    Eur J Cardiothorac Surg; 2004 Aug; 26(2):270-5. PubMed ID: 15296882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial protection: the efficacy of an ultra-short-acting beta-blocker, esmolol, as a cardioplegic agent.
    Bessho R; Chambers DJ
    J Thorac Cardiovasc Surg; 2001 Nov; 122(5):993-1003. PubMed ID: 11689806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of hypercarbic acidotic reperfusion on recovery of myocardial function after cardioplegic ischemia in neonatal lambs.
    Nomura F; Aoki M; Forbess JM; Mayer JE
    Circulation; 1994 Nov; 90(5 Pt 2):II321-7. PubMed ID: 7955274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced tolerance of global ischemia in the hypertrophied heart. Effect of coronary flow regulation during reperfusion on postischemic recovery.
    Yamamoto H; Yamamoto F; Goh K; Sasajima T
    Jpn J Thorac Cardiovasc Surg; 2001 May; 49(5):287-95. PubMed ID: 11431947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normocalcemic blood or crystalloid cardioplegia provides better neonatal myocardial protection than does low-calcium cardioplegia.
    Pearl JM; Laks H; Drinkwater DC; Meneshian A; Sun B; Gates RN; Chang P
    J Thorac Cardiovasc Surg; 1993 Feb; 105(2):201-6. PubMed ID: 8429645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of ischemic vulnerability and responsiveness to cardioplegic protection in crystalloid-perfused versus blood-perfused hearts.
    Qiu Y; Hearse DJ
    J Thorac Cardiovasc Surg; 1992 May; 103(5):960-8. PubMed ID: 1569777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.